U.S. EPA Licenses Simulations Plus’ Admet Predictor™ Software
News Jun 18, 2008
Simulations Plus, Inc. has announced that it has received a purchase order from the U.S. Environmental Protection Agency for its ADMET Predictor™ software.
Ron Creeley, vice president of marketing and sales for Simulations Plus, said: “This is our first software license from the EPA. We’re especially pleased that they have recognized the value of ADMET Predictor’s Toxicity Module and our new Enslein Metabolism Module in their work. Many people don’t realize that in addition to pesticides and industry chemicals, drugs also can pose a potential environmental hazard, because a large portion of drugs are thrown away instead of being taken.”
“Eventually these drugs, as well as the excipients that are packaged with them, end up in our sewage treatment and landfill systems, from which they can reach fresh water streams and the oceans, or they can be blown into the air as dust and spread over large areas. So it’s important for both the EPA, the chemical industry, and drug manufacturers to consider not only how new molecules accomplish their designed purpose, but also how the environment could be affected if and when they get into our air or water,” Creeley continued.
Exposure to Low Levels of BPA during Pregnancy Can Lead to Altered Brain DevelopmentNews
New research in mice provides an explanation for how exposure to the widely used chemical bisphenol A (BPA) during pregnancy, even at levels lower than the regulated “safe” human exposure level, can lead to altered brain development and behavior later in life.READ MORE
Moving Toward a Future Free of Drug-Induced Hearing LossNews
A new special publication orchestrated by five of the nation's leading hearing experts compiles the latest research into hearing loss caused by drugs and solvents - how it occurs, how to treat it, and how to prevent it.READ MORE
3-D Tissue Model of Developing Heart Could Aid Drug Safety Testing for Pregnant WomenNews
Parents and doctors often have to consider the mother's health as well as the potential risk regarding how medication could affect their baby. Researchers have developed a process to make a 3D tissue model that could mimic early stage human heart development, which could aid drug safety testing and help determine a drug's effects on fetal development.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018